Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.51
Delayed Data
As of Jun 28
 +0.02 / +4.08%
Today’s Change
0.39
Today|||52-Week Range
2.64
-26.07%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Equels Thomas Kenwood
President & Chief Executive Officer
Buy4/11/2017200,000$0.50$100.0K-8.93%
Equels Thomas Kenwood
President & Chief Executive Officer
Buy4/27/201772,464$0.69$50.0K-23.90%
Equels Thomas Kenwood
President & Chief Executive Officer
Buy12/22/201668,493$0.73$50.0K-26.09%
Appelrouth Stewart L
Director
Buy8/24/201615,750$2.21$34.8K-75.99%
Equels Thomas Kenwood
President & Chief Executive Officer
Buy11/01/201610,000$1.00$10.0K-44.78%
Springate Wayne S
Senior Vice President-Operations
Buy5/02/201715,873$0.63$10.0K-23.65%
Rodino Peter W Iii
Buy5/02/201715,873$0.63$10.0K-23.65%
Pascale Adam
Chief Financial Officer
Buy5/02/201715,873$0.63$10.0K-23.65%
Strayer David R
Buy5/02/20177,937$0.63$5.0K-23.65%
Strayer David R
Buy2/16/20179,892$0.46$4.6K+10.87%
Page of 2